231 filings
Page 7 of 12
6-K
fx8jxfdeyyl21ck
2 Mar 21
Current report (foreign)
4:07pm
6-K
j66wyi
2 Mar 21
Report of Foreign Private Issuer
4:05pm
6-K
9xtjjp58c9fuh8srhhos
1 Mar 21
Current report (foreign)
4:00pm
6-K
iki jpkhdn936b7ck0a
24 Feb 21
SciSparc Corporate Presentation February 2021
9:27am
6-K
i38zql 95rggm
17 Feb 21
Report of Foreign Private Issuer
8:35am
6-K
yzxmmxiebo4
11 Feb 21
SciSparc Announces Rebranding and Business Updates
10:01am
6-K
ades7bwk 6du
10 Feb 21
SciSparc Engages Procaps for Development and Production of CannAmideā¢ and its SCI-110 Product Candidate
8:33am
6-K
jpnqmi7b12 qw6c7
9 Feb 21
SciSparc Initiates Commercial Production of its CannAmideā¢ Pills
8:36am
6-K
i0p0zon5
28 Jan 21
Report of Foreign Private Issuer
9:36am
6-K
jlzbrs564m4
25 Jan 21
Special General Meeting of Shareholders
5:27pm
6-K
j1a89h7s9si
7 Jan 21
Report of Foreign Private Issuer
5:00pm
6-K
onatudxs7lqxga
6 Jan 21
Report of Foreign Private Issuer
11:53am
6-K
l78l bgba2zp3ug122w
5 Jan 21
Therapix Biosciences and Cyntar Ventures Entered a Non-Binding Letter of Intent for the Distribution of TheraPEA in Canada
9:12am
6-K
ffyqgkbz wpj
31 Dec 20
Report of Foreign Private Issuer
2:02pm
6-K
xt6l3djmvl5sj15 i3qa
15 Dec 20
Report of Foreign Private Issuer
10:55am
6-K
wcxh hvhw76
8 Dec 20
Therapix Biosciences Announces Upgrade to OTCQB Venture Market
9:36am
6-K
p8d26kb9
2 Dec 20
Special General Meeting of Shareholders
4:02pm
6-K
npfhxuipf432fms
2 Dec 20
Therapix Biosciences to Collaborate with The University of Calgary to Further Examine its Proprietary Drug Candidate THX-160 for Pain
9:25am
6-K
6rsej6
24 Nov 20
Therapix Biosciences Announces Pricing of $4.2 Million Offering
1:13pm
6-K
pxzxk
16 Oct 20
Report of Foreign Private Issuer
4:05pm